420 with CNW – American Cannabis Sales Expected to Double on 4/20

For the uninitiated, 4/20 in the marijuana industry can be equated to Fourth of July. The exact origin of that “holiday” isn’t known, but there is speculation that the day is named after the time of the day (4:20 p.m.) when a group of students would meet outside their high school in the 1970s to hunt for some legendary cannabis plants that had been abandoned. According to that myth, those students never found that marijuana crop, so they doggedly kept up their search.

On 4/20, sales of marijuana are expected to, at the very least, double at all retail facilities in the U.S. states where recreational cannabis is legal.

This projection is drawn from the data collected by Headset Inc. The statistics show that historically, 4/20 has been the busiest day for pot sellers. This is especially true when that date falls on a Friday.

According to Headset Inc., 4/20 last year saw a 111 percent jump in sales when the sales on that day were compared to the cannabis sales on four Fridays before that day and another four after the “holiday.” The data analyzed was taken from Washington State, Nevada, Colorado and California.

In comparison, beer sales registered a modest jump in the two weeks that included July 4. Only a 33 percent rise in sales was discovered when the number crunchers did the math. This shows that cannabis “holidays” draw a more enthusiastic weed buyer response when compared to the way beer consumers behave on July 4.

Another way to see it would be that the trajectory of cannabis sales is on a sharp rise while beer sales reached their peak long ago, so holidays cannot trigger major movements in the market.

As already indicated, last year’s 4/20 fell on a Friday, a day when cannabis consumers seem to visit retail outlets more. This year’s 4/20 will be on Saturday, so that brings even better news to recreational cannabis retailers since the “eve” of 4/20 will be a magnet to buyers and the “holiday” itself will also inspire cannabis consumers to spend on weed. Chances are therefore high that marijuana sales will be record-breaking during that long Easter weekend.

The cannabis crowd across the border in Canada will not enjoy the day as much as their American counterparts will. This is because any added demand for recreational cannabis in Canada will be dampened by the persistent supply shortages that have refused to go away since weed was legalized on October 17, 2018.

Queues will be longer on that day, especially in places like Toronto where retail facilities are limited. And unfortunately, not all who line up will leave a retail store with their first-choice cannabis product. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) look forward to the day when there will be no more cannabis shortages in Canada so that the people there can access all the products that they want.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Student-Organized Event Discusses Cannabis on Sidelines of Michigan Hash Bash

Every year, a Hash Bash festival is held in Ann Arbor as a day of having fun and entertainment. This year, law students at Michigan Law School worked with the organizers of the Hash Bash festival to host an event at the law school to discuss marijuana legalization politics.

This event was held yesterday (Sunday, April 7) while the Hash Bash took place on Saturday. The organizers of the event at Michigan Law School wanted to educate members of the public about issues related to marijuana. Several panelists made presentations on various issues.

Ari Goldstein, a law student who was one of the organizers, remarked that marijuana legalization brings entrepreneurial opportunities that haven’t been seen since the Great Depression, so every effort must be taken to prepare people to seize those opportunities.

Kevin Boehnke, who is a research fellow at Michigan University’s Department of Anesthesiology, revealed during his presentation that several patient studies point to the fact that more patients are opting for medical marijuana to manage pain instead of using prescription opioids.

The shift is due to the better symptom relief experienced by patients, and the concerns about the documented side effects of prescription opioids.

Another panelist, Gus Rosania (a professor of pharmacological sciences) handled the topic of natural vs. synthetic cannabis ingredients. Rosania dispelled the misconception that synthetic cannabis is different from natural cannabis.

He revealed that at the basic level, synthetic marijuana is chemically identical to natural marijuana, so it is hard to tell the two apart. He added that it was only because different ingredients could be isolated and made in a lab that it was possible to identify the different cannabinoids in marijuana.

Andrew Brisbo, the head of Michigan’s Bureau of Marijuana Regulation, was also in attendance to talk about the ramifications of the legalization of recreational cannabis in the state. He revealed that he had a huge task on his desk to put together a program for recreational cannabis implementation in just a year from the time the law was passed.

Brisbo intimated that one way that he was using to get everything done correctly is by engaging different stakeholders in order to tap their perspectives when putting together an implementation plan.

Many people in the audience expressed their frustration about how hard it was for them to get a medical cannabis prescription from their doctors. Brisbo expressed sympathy for their plight and revealed that it wasn’t easy to change attitudes about cannabis after such a long time of prohibition. He added that efforts were underway to give physicians more information about medical cannabis so that they can gradually warm up to prescribing it to their patients who qualify for such treatment.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America, Inc. (OTCQB: MCOA) welcome such engagements between regulators, patients, professors and other stakeholders since such interactions can result in better cannabis industry policies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Utah Moves to Hire Software Provider for Medical Marijuana Program

After passing a medical marijuana law in December 2018, Utah has now engaged high gear in moving towards implementing the program. The state is currently looking for a software provider who will design a two-part system that will, in effect, run the entire medical cannabis program.

One part of the system will track each medical cannabis plant from the time it reaches eight inches tall to the point when it is bought by a patient registered to use medical marijuana in the state.

Tracking the plants is important because the state will be sure that legally grown weed isn’t being channeled to the black market.

The second part of the software will be used to enroll patients on the medical cannabis program, store information about the prescriptions issued by doctors and keep track of how much medical cannabis each patient is buying.

The state will have a big decision to make regarding whether one provider will be sufficient for the two components of the medical cannabis system or multiple providers should be sourced for the different aspects of the system.

State officials want to select the firms that will provide the software by May so that the second half of the year is devoted to selecting medical marijuana cultivators. The deadline for starting to receive applications from patients who want to use medical marijuana is March 1, 2020, but the officials want to start receiving applications earlier than that date, if possible.

However, eyebrows have been raised about the plan to allow law enforcement to access the system. Advocates are concerned that the police or any other law enforcement agency (state or federal) may abuse that access they are granted.

The state insists that law enforcement will only be allowed to confirm whether someone is authorized to possess medical cannabis or not. Other details, such as the qualifying condition for which a patient got approval to use medical cannabis, will be inaccessible to law enforcement.

The software program is expected to cost anywhere from $2 million to $5 million. This amount will cover the cost of building as well as running the system for its first five years of existence.

To put this cost into perspective, think about what Pennsylvania spent for a similar system. The state spent $10.4 million for building and operating its system for five years.

However, Nevada spent approximately $816,000 to acquire and operate a traceability system for its medical cannabis program for four years. Traceability covers just half of what Utah is seeking, but you can get a picture of how the costs compare.

Marijuana Company of America, Inc. (OTCQB: MCOA) and Medical Cannabis Payment Solutions (OTC: REFG) hope that the provider selected designs and implements a system that will not be plagued by the glitches that have disrupted medical cannabis programs in other states.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Workers’ Compensation Being Modified to Incorporate Medical Cannabis in Canada

You would expect that with more than 17 years of existence in Canada, medical cannabis should have already led to policy changes in various aspects of life in the country. However, if the claims of injured workers are anything to go by, workers’ compensation guidelines have been slow in changing to accommodate this form of treatment. Now matters are beginning to shift as the discussion below shows.

More Workers Winning in Tribunals

Mellissa Ellsworth is just one of 10 patients who have won hearings in Nova Scotia’s workers’ comp tribunal set up to assess whether the Workers’ Compensation Board should cover the cost of medical marijuana. It took her five years to get this approval.

Alberta’s board has so far also accepted to cover the medical marijuana costs of 10 workers who were injured on the job. New Brunswick shines in this regard because it has so far approved 71 patients’ applications for medical cannabis costs coverage under workers’ comp policies.

It is saddening that patients have to endure years of pain as their applications slowly make their way through the red tape of the Workers’ Compensation Boards in the different provinces and territories. For example, the neurological pain experienced by Melissa Ellsworth led her to take a total of 26 pills on a daily basis just to function as a normal human. She now takes only cannabis and enjoys a better quality of life.

The good news amidst all this is that for each patient who gets approval, more are encouraged to table their requests before the different boards. Eventually, medical cannabis will become a normal form of treatment and no patient will have to go through what the pioneers like Melissa Ellsworth had to endure to get approval.

Doctors’ Prescriptions Rarely Considered

You would think that the different Workers’ Compensation Boards would attach some weight to the recommendations provided by the primary healthcare providers of the patients who apply for coverage.

However, only Quebec recognizes and acts upon those recommendations. Other boards convene their own medical team sittings to assess the eligibility of a patient for medical cannabis. Why should this happen when Health Canada screens patients before giving them a medical cannabis card?

Caps on Daily Cannabis Consumption

Nearly all provinces and territories that are even willing to consider paying for medical cannabis for injured workers impose a three gram cap on how much medical cannabis a patient can claim coverage for each day.

While there may be valid reasons for this cap, it would be reasonable for these boards to acknowledge that different patients have different needs, so mechanisms should be available for those who need more to be covered without major hassles. Even Health Canada allows patients to grow hundreds of cannabis plants if they need a lot on a daily basis for their treatment. But, workers’ comp boards still insist on three grams a day!

But, There’s Progress…

Amidst this huge cloud hovering over injured workers in Canada, winds of change are slowly picking up. Last year, New Brunswick set the stage by passing medical cannabis guidelines. Prince Edward Island followed suit, and now Nova Scotia is drafting its own set of guidelines.

While all this is happening in Canada, one wonders what the situation is here in the U.S. With most marijuana businesses still struggling to access banking services, it is hard to picture what patients may be going through if they wish to have their medical cannabis costs covered by workers’ comp insurance. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) decry the slow rate at which workers’ compensation is evolving to accommodate medical cannabis. This isn’t only denying patients a viable treatment option, but it is also limiting the investment opportunities that would boost the economy.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Smart Investment Leads to Big Opportunities in Growing Cannabis Market

CannabisNewsWire Editorial Coverage: As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

  • Cannabis and related products are legal in an ever-increasing number of jurisdictions.
  • Businesses have responded with an increasingly diverse range of products.
  • Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Marijuana Company of America Inc. (OTCQB: MCOA) (MCOA Profile), with its hemp-oriented business, is expecting a surge in profits following the crop’s federal legalization in the United States in December. Medical Marijuana Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, has seen record sales. PotNetwork Holdings Inc. (OTC: POTN) is reaching out to new customers with a CBD-infused slushy machine. And American Premium Water Corp. (OTC: HIPH) is also pushing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – This is How Much Recreational Pot Canadians Bought in 2018

If you were asked to make a random guess about how much weed Canadians bought (and presumably consumed) since recreational marijuana was legalized in October last year, what would you say? Well, Statistics Canada released recreational cannabis sales data and the figures are surprising, to say the least.

The statistics show that in October last year, Canadians bought recreational cannabis worth $32.7 million while November sales amounted to $40.4 million. In December, Canadians bought recreational cannabis products worth $41.9 million.

These figures are considered to be highly reliable because the Canadian marijuana market is highly regulated. You should therefore not doubt that the first three months of legal recreational pot resulted in total sales of $115 million. That is shocking, given all the hype that accompanied the lead up to legalization.

However, a number of factors may explain why annual recreational cannabis sales are likely to be far less than was predicted.

First, the persistent supply shortages have made it hard for all Canadian who would like to use weed to buy the substance as often as they would like. Without weed on the shelves, where would the sales come from? Many licensed producers predict that it may take years for them to ramp up their production to a level that can meet the current demand.

Secondly, Health Canada has also played a part in dampening the performance of the recreational cannabis sector. The regulator has been very slow in processing the applications for the different entities that would like to become licensed producers/cultivators of cannabis in the country. There are claims that Health Canada takes several months or even years to make a decision on an application. This sluggish way of conducting their business has made it hard for enough producers to be active in the country, hence the supply shortages.

Another reason for the low recreational cannabis sales has to do with a shortage of packaging and processing facilities. There are reports that harvested cannabis takes unnecessarily long to reach the shelves of retail outlets because the few processers licensed in the country cannot handle the volume of weed available for processing and packaging.

Not surprisingly, the packaging and processing problem also goes back to Health Canada who have been slow in issuing processing or packaging licenses to interested players.

Finally, the provinces may also have a role to play in the dismal sales statistics. For example, Ontario has only been selling recreational cannabis through the state-run online outlets. While there are plans to open offline stores, the current sale in online stores alone has reduced the potential sales that would have been made in the densely populated cities within the province.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) look forward to a speedy resolution of all the limiting factors above so that the Canadian cannabis industry can reach its full potential.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – California Rakes in $300 Million in Cannabis Taxes in 2018

The statistics are out; California earned approximately $300 million in taxes during the first year of recreational cannabis sales in the state. This information was released by the Department of Tax and Fee Administration in California on February 19.

While the $300 million tax collection is high, it is way below what the state had initially anticipated to collect during the first year of commercial cannabis sales ($655 million). Two reasons may explain why the taxes collected were below the projected figure.

First, it is hard to predict with any degree of certainty what quantity of cannabis will be sold if the state doesn’t have any historical data to rely upon when making those projections. Any figure arrived at is therefore likely to be a “guesstimate” at best.

Secondly, most city and local authorities, up to 75 percent of them, banned any business activity related to cannabis within their jurisdictions. This meant that recreational cannabis could only be accessed in a few areas within the state.

This same scenario played out in all the states where recreational cannabis was legalized. However, those local authorities gradually came around and permitted cannabis businesses to open so that residents can get jobs and the local authorities can also collect taxes.

California also expects more local authorities to come on board and cannabis sales will soar once access is ramped up in more cities and municipalities.

Another important fact to note about the taxes collected by California in 2018 is that the other states that also ended prohibition in 2016 earned “peanuts” if their collections are compared to California’s.

For example, Nevada collected only $69.8 million while Massachusetts is likely to collect $60 million once it completes its first year of recreational sales.

The collections in those other states are understandable because none of them comes even close to the size of California’s economy.

California is justified to be optimistic about future tax revenues from recreational marijuana because an analysis of the 2018 taxes shows that there was a general upward trend from one quarter to the next. This clearly paints a bullish picture for the industry going forward.

More reason for optimism also comes from the fact that the earnings in just 2018 triple or more than triple the annual taxes that the state had ever collected from the sale of medical marijuana throughout the 23 years when medical cannabis was available in the state.

While California seems to be on course to collect $1 billion as tax revenue from recreational marijuana sales within three years, industry players are crying out for a reduction in the taxes levied. It remains to be seen whether their calls will be heeded by the lawmakers since any change requires a supermajority before Proposition 64 can be amended.

Marijuana Company of America, Inc. (OTCQB: MCOA) and Medical Cannabis Payment Solutions (OTC: REFG) congratulate California for setting a record of taxes earned from recreational cannabis sales.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Says Dabbing is the Most Efficient Way to Consume Cannabis

Have you ever wondered which delivery method offers the best results when you are consuming cannabis? A recent study has concluded that “dabbing” is superior to the other common ways of getting cannabis into your bloodstream.

Forensic Science International conducted the study whose findings showed that “dabbing” delivered at least 75 percent of the THC in cannabis to your lungs. This is in contrast to smoking which destroys the same percentage (75 percent) of THC before it can reach your lungs.

Dabbing refers to inhaling the vapor from a heated extract of cannabis. The extract is heated to boiling point on a ceramic, titanium or quartz surface.

The experiment involved the use of a machine that was built by Forensic Science International specifically for this research. This machine was able to replicate smoking and dabbing. The researchers collected the smoke which would have made its way into someone’s lungs and they analyzed those samples to know how much CBD and THC they contained. This proportion formed what they called the “recovery rate” of those delivery methods.

The recovery rates stated above (75 percent for dabbing and 25 percent for smoking) were established after analyzing the collected samples.

Previous studies had put the recovery rate for smoking at 27.5-46.3 percent, which is still a far cry from the 75 percent registered for dabbing. Other research also gave vaping a higher recovery rate (51.4-82.7 percent) when compared to smoking. The recovery rates for vaping varied based on the specific vaporizer that one was using.

However, these studies on the recovery rates of the different cannabis delivery methods should be regarded with some caution because the results were clearly dependent on the temperature used during dabbing. Lower temperatures tended to give higher recovery rates, partly because a smaller proportion of the ingredients in cannabis was destroyed by the heat while higher temperatures reduced the recovery rates of dabbing to just over 50 percent.

Another factor that may contribute to the results obtained is the composition of the extracts used during dabbing. For example, heating the “acid form” of THC, called THCA, resulted in higher recovery rates because when that THCA was heated, it produced THC. Conversely, heating THC reduced the recovery rate because once you heat THC, some of it becomes something else, thereby reducing the quantity of THC reaching the lungs.

Similarly, smoking cannabis shouldn’t be dismissed as a wasteful way to consume cannabis. After all, consumers agree they get a range of physiological effects when they smoke. This may be due to some of the new compounds created once THC is heated. Thus, cannabis smokers may derive special experiences that aren’t available to those who use other delivery methods.

The bottom line? Whatever method you use to consume your cannabis will deliver the benefits expected by the industry players, such as Marijuana Company of America Inc. (OTCQB: MCOA) and Medical Cannabis Payment Solutions (OTC: REFG). Only the degree of those effects will vary.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – What is CBD, and what is its Relationship with THC?

People who have heard about CBD-infused drinks, cosmetics and pet food may be wondering why that cannabis extract isn’t attracting as much polarized attention as THC. Read on and learn everything that you need to know about CBD and THC, and why CBD is gaining in popularity in nearly every industry.

A Brief Primer on Cannabinoids…

The cannabis plant has more than 100 different compounds within it. These are called cannabinoids and terpenes, so you should therefore not imagine that the cannabis plant has only two compounds. However, two of the most abundant cannabinoids in the cannabis plant are CBD (cannabidiol) and THC (tetrahydrocannabinol).

THC is the psychoactive cannabinoid that makes cannabis consumers “high” while CBD isn’t psychoactive.

Marijuana vs. Hemp?

Cannabis is a general term used to refer to a family of plants that have similar compounds (cannabinoids). Marijuana and hemp are therefore members of the same family.

However, hemp has a very small amount of THC in it. The U.S. federal government describes a given plant in the cannabis family as hemp if that plant has less than 0.3 percent concentration of THC. By the same token, marijuana is the other member of the cannabis family that has THC levels that are higher than the threshold for the hemp plant.

Remember, “hemp” and “marijuana” are arbitrary terms given to the same plant only that the level of THC determines which of those two words you will use to refer to the plant you are looking at.

Why is CBD Readily Available Yet Marijuana is Illegal?

As already mentioned, CBD is one of the non-psychoactive compounds found in the cannabis plant. This cannabinoid has several medicinal properties, such as anxiety, pain and insomnia relief.

Recently, President Trump signed into law the Farm Bill of 2018 and this law changed the legal status of hemp to an agricultural product (just like soy, corn or any other plant). Consequently, extracting CBD oil from hemp doesn’t break any U.S. law.

In contrast, marijuana is a Schedule 1 controlled substance that is illegal at the federal level. However, dozens of states have legalized medical marijuana and nearly a dozen have legalized adult-use marijuana.

The laws and attitudes surrounding marijuana haven’t affected the reputation of CBD and that is why it is widely available.

Do Consumers of CBD Face Any Safety Risks?

Interestingly, nearly all the literature available on CBD says that it is safe for consumption. However, little is known about how this compound may interact with other substances, such as conventional medications, in the body.

Additionally, CBD extracts haven’t been used for a long enough time to assess their effects on pregnant women and their unborn babies. Caution is therefore recommended for people in high-risk categories (expectant mothers and babies, for example).

As you can see, CBD seems set to continue on its forward march now that hemp is an agricultural product that can be widely cultivated for various purposes. Cannabis industry players like Marijuana Company of America, Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) would like to see a time when marijuana is accepted the way hemp is now accepted.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – South Carolina Legislators Introduce Bill to Legalize Medical Marijuana

It seems South Carolina is next in line to act upon the growing popularity of marijuana across the U.S. Two legislators have tabled a bill that, if passed, would allow patients to start using medical marijuana.

The Compassionate Care Act is sponsored by Rep. Peter McCoy and Sen. Tom Davis. When unveiling the bill, Sen. Davis said that their interest in introducing that bill was to make it possible for patients and their doctors to decide whether medical marijuana can be helpful in promoting the health of the patient. Such a decision should not be left to politicians or law enforcement agencies, he added.

True to the conservative nature of South Carolina, the proposed bill comes with numerous restrictions to prevent the program from being abused by those who wish to consume recreational marijuana.

For example, physicians will constantly monitor how the patients they recommended are using medical marijuana.

The bill also limits the qualifying conditions for which one can obtain a medical cannabis card. Only patients with chronic conditions will be eligible to get medical marijuana cards if the bill is passed in its current form. This is unlike some other states where nearly everyone can apply and receive a medical marijuana license since the qualifying conditions are loosely defined.

Currently, about 72 percent of people in South Carolina support the legalization of medical cannabis. The sponsors of this bill are counting on that popular support to see the bill through the legislature.

However, it will not be smooth sailing for the proposed law. There is opposition from different sections of the community, such as law enforcement and some members of the medical profession.

The Chairman of South Carolina’s Medical Association, Dr. John Ropp, is one of those who are vehemently opposed to the legalization of medical marijuana. He says that cannabis has been prohibited for approximately 50 years and it remains a Schedule 1 substance. This means that there is insufficient scientific data regarding its efficacy as a medicine. He adds that cannabis can only be used as a medicine once peer-reviewed studies show that it has medicinal value.

That is the same argument that the FDA, DEA and other federal agencies have been pushing, and yet the current federal legal regime continues to make it hard for researchers to study the plant and obtain the needed scientific backing for its use as a medicine.

All the same, Sen. Davis and Rep. McCoy are pressing ahead with the bill, and if it doesn’t succeed then a ballot measure may be on the cards. The cannabis industry, including Medical Cannabis Payment Solutions (OTC: REFG) and Marijuana Company of America, Inc. (OTCQB: MCOA) hopes that consensus is quickly built so that the patients who badly need medical cannabis can access it legally within the state.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com